Industry-Expert Theater

Optimizing Treatment in Unresectable Stage III Non-small Cell Lung Cancer: Treatment for Unresectable Stage III NSCLC Following Concurrent Chemoradiation Therapy

Sunday, September 15
12:15 PM - 1:15 PM
Location: Theater 2, Innovation Hub

Speaker:
Roy Decker, MD, PhD
Professor
Vice Chair for Clinical Research
Department of Therapeutic Radiology
Yale School of Medicine

Company: AstraZeneca
Contact: Joyce Cao
Phone: 408-916-6004
Email: joyce.cao@astrazeneca.com


Assets

Optimizing Treatment in Unresectable Stage III Non-small Cell Lung Cancer: Treatment for Unresectable Stage III NSCLC Following Concurrent Chemoradiation Therapy



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Optimizing Treatment in Unresectable Stage III Non-small Cell Lung Cancer: Treatment for Unresectable Stage III NSCLC Following Concurrent Chemoradiation Therapy